日本内科学会雑誌第98巻第4号
|
|
|
- きよたつ わかはら
- 5 years ago
- Views:
Transcription
1
2 α
3
4
5 α
6
7 γ
8
9 γ
10
11
12
13 γ α
14
15
16 β
17 α
18
19
20 β
21
22 γ
O1-1 O1-2 O1-3 O1-4 O1-5 O1-6
O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-7 O1-8 O1-9 O1-10 O1-11 O1-12 O1-13 O1-14 O1-15 O1-16 O1-17 O1-18 O1-19 O1-20 O1-21 O1-22 O1-23 O1-24 O1-25 O1-26 O1-27 O1-28 O1-29 O1-30 O1-31 O1-32 O1-33 O1-34 O1-35
1 911 9001030 9:00 A B C D E F G H I J K L M 1A0900 1B0900 1C0900 1D0900 1E0900 1F0900 1G0900 1H0900 1I0900 1J0900 1K0900 1L0900 1M0900 9:15 1A0915 1B0915 1C0915 1D0915 1E0915 1F0915 1G0915 1H0915 1I0915
研修コーナー
l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
_0212_68<5A66><4EBA><79D1>_<6821><4E86><FF08><30C8><30F3><30DC><306A><3057><FF09>.pdf
第86回日本感染症学会総会学術集会後抄録（I）
κ κ κ κ κ κ μ μ β β β γ α α β β γ α β α α α γ α β β γ μ β β μ μ α ββ β β β β β β β β β β β β β β β β β β γ β μ μ μ μμ μ μ μ μ β β μ μ μ μ μ μ μ μ μ μ μ μ μ μ β
平成20年5月 協会創立50年の歩み 海の安全と環境保全を目指して 友國八郎 海上保安庁 長官 岩崎貞二 日本船主協会 会長 前川弘幸 JF全国漁業協同組合連合会 代表理事会長 服部郁弘 日本船長協会 会長 森本靖之 日本船舶機関士協会 会長 大内博文 航海訓練所 練習船船長 竹本孝弘 第二管区海上保安本部長 梅田宜弘
![Œ{Ł¶/1ŒÊ −ªfiª„¾ [ 1…y†[…W ]](/thumbs/50/26134150.jpg "Œ{Ł¶/1ŒÊ −ªfiª„¾ [ 1…y†[…W ]")
zsj2017 (Toyama) program.pdf
88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88
88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88
_170825_<52D5><7269><5B66><4F1A>_<6821><4E86><5F8C><4FEE><6B63>_<518A><5B50><4F53><FF08><5168><9801><FF09>.pdf
88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88
ｎｓｇ０４－２８／ｋｙ２０８６８４３５６１０００４３０７７
δ!!! μ μ μ γ UBE3A Ube3a Ube3a δ !!!! α α α α α α α α α α μ μ α β α β β !!!!!!!! μ! Suncus murinus μ Ω! π μ Ω in vivo! μ μ μ!!! ! in situ! in vivo δ δ !!!!!!!!!! ! in vivo Orexin-Arch Orexin-Arch !!
( )
) ( ( ) 3 15m t / 1.9 3 m t / 0.64 3 m ( ) ( ) 3 15m 3 1.9m / t 0.64m 3 / t ) ( β1 β 2 β 3 y ( ) = αx1 X 2 X 3 ( ) ) ( ( ) 3 15m t / 1.9 3 m 3 90m t / 0.64 3 m ( ) : r : ) 30 ( 10 0.0164
NL09
Information September, 2005 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.9 September, 2005 3 2005 4 Japanese Association for Molecular Target Therapy of Cancer News Letter
> > <., vs. > x 2 x y = ax 2 + bx + c y = 0 2 ax 2 + bx + c = 0 y = 0 x ( x ) y = ax 2 + bx + c D = b 2 4ac (1) D > 0 x (2) D = 0 x (3
13 2 13.0 2 ( ) ( ) 2 13.1 ( ) ax 2 + bx + c > 0 ( a, b, c ) ( ) 275 > > 2 2 13.3 x 2 x y = ax 2 + bx + c y = 0 2 ax 2 + bx + c = 0 y = 0 x ( x ) y = ax 2 + bx + c D = b 2 4ac (1) D >
202
202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 DS =+α log (Spread )+ β DSRate +γlend +δ DEx DS t Spread t 1 DSRate t Lend t DEx DS DEx Spread DS
ｎｓｇ０２－１３／ｋｙ０４５０５９３０１６０００３３２１０
φ φ φ φ κ κ α α μ μ α α μ χ et al Neurosci. Res. Trpv J Physiol μ μ α α α β in vivo β β β β β β β β in vitro β γ μ δ μδ δ δ α θ α θ α In Biomechanics at Micro- and Nanoscale Levels, Volume I W W v W
ax 2 + bx + c = n 8 (n ) a n x n + a n 1 x n a 1 x + a 0 = 0 ( a n, a n 1,, a 1, a 0 a n 0) n n ( ) ( ) ax 3 + bx 2 + cx + d = 0 4
20 20.0 ( ) 8 y = ax 2 + bx + c 443 ax 2 + bx + c = 0 20.1 20.1.1 n 8 (n ) a n x n + a n 1 x n 1 + + a 1 x + a 0 = 0 ( a n, a n 1,, a 1, a 0 a n 0) n n ( ) ( ) ax 3 + bx 2 + cx + d = 0 444 ( a, b, c, d
4 4 θ X θ P θ 4. 0, 405 P 0 X 405 X P 4. () 60 () 45 () 40 (4) 765 (5) 40 B 60 0 P = 90, = ( ) = X
4 4. 4.. 5 5 0 A P P P X X X X +45 45 0 45 60 70 X 60 X 0 P P 4 4 θ X θ P θ 4. 0, 405 P 0 X 405 X P 4. () 60 () 45 () 40 (4) 765 (5) 40 B 60 0 P 0 0 + 60 = 90, 0 + 60 = 750 0 + 60 ( ) = 0 90 750 0 90 0
1 12 *1 *2 (1991) (1992) (2002) (1991) (1992) (2002) 13 (1991) (1992) (2002) *1 (2003) *2 (1997) 1
2005 1 1991 1996 5 i 1 12 *1 *2 (1991) (1992) (2002) (1991) (1992) (2002) 13 (1991) (1992) (2002) *1 (2003) *2 (1997) 1 2 13 *3 *4 200 1 14 2 250m :64.3km 457mm :76.4km 200 1 548mm 16 9 12 589 13 8 50m
日歯雑誌（Ｈ２８・８月号）別刷り／ポスターセッション とびら
α P. gingivalis P. gingivalis αsmatgf- VEGF-A α in vitro μ Porphyromonas gingivalis in vitro Porphyromonas gingivalis β β β JBiolChem. μ μ μ β Porphyromonas gingivalis in vitro μ α β α
N cos s s cos ψ e e e e 3 3 e e 3 e 3 e
3 3 5 5 5 3 3 7 5 33 5 33 9 5 8 > e > f U f U u u > u ue u e u ue u ue u e u e u u e u u e u N cos s s cos ψ e e e e 3 3 e e 3 e 3 e 3 > A A > A E A f A A f A [ ] f A A e > > A e[ ] > f A E A < < f ; >
3/4/8:9 { } { } β β β α β α β β
α β : α β β α β α, [ ] [ ] V, [ ] α α β [ ] β 3/4/8:9 3/4/8:9 { } { } β β β α β α β β [] β [] β β β β α ( ( ( ( ( ( [ ] [ ] [ β ] [ α β β ] [ α ( β β ] [ α] [ ( β β ] [] α [ β β ] ( / α α [ β β ] [ ] 3
y = x x R = 0. 9, R = σ $ = y x w = x y x x w = x y α ε = + β + x x x y α ε = + β + γ x + x x x x' = / x y' = y/ x y' =
y x = α + β + ε =,, ε V( ε) = E( ε ) = σ α $ $ β w ( 0) σ = w σ σ y α x ε = + β + w w w w ε / w ( w y x α β ) = α$ $ W = yw βwxw $β = W ( W) ( W)( W) w x x w x x y y = = x W y W x y x y xw = y W = w w
n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m
![n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m](/thumbs/94/118912662.jpg "n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m")
1 1 1 + 1 4 + + 1 n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m a n < ε 1 1. ε = 10 1 N m, n N a m a n < ε = 10 1 N
内科９６巻３号★／ＮＡＩ３‐１（第２２回試験問題）
µ µ α µ µ µ µ µ µ β β α γ µ Enterococcus faecalis Escherichia coli Legionella pneumophila Pseudomonas aeruginosa Streptococcus viridans α β 正解表正解記号問題 No. 正解記号問題 No. e(4.5) 26 e 1 a(1.2) 27 a 2
F = 0 F α, β F = t 2 + at + b (t α)(t β) = t 2 (α + β)t + αβ G : α + β = a, αβ = b F = 0 F (t) = 0 t α, β G t F = 0 α, β G. α β a b α β α β a b (α β)
19 7 12 1 t F := t 2 + at + b D := a 2 4b F = 0 a, b 1.1 F = 0 α, β α β a, b /stlasadisc.tex, cusp.tex, toileta.eps, toiletb.eps, fromatob.tex 1 F = 0 F α, β F = t 2 + at + b (t α)(t β) = t 2 (α + β)t
O x y z O ( O ) O (O ) 3 x y z O O x v t = t = 0 ( 1 ) O t = 0 c t r = ct P (x, y, z) r 2 = x 2 + y 2 + z 2 (t, x, y, z) (ct) 2 x 2 y 2 z 2 = 0
9 O y O ( O ) O (O ) 3 y O O v t = t = 0 ( ) O t = 0 t r = t P (, y, ) r = + y + (t,, y, ) (t) y = 0 () ( )O O t (t ) y = 0 () (t) y = (t ) y = 0 (3) O O v O O v O O O y y O O v P(, y,, t) t (, y,, t )
70 : 20 : A B (20 ) (30 ) 50 1
70 : 0 : A B (0 ) (30 ) 50 1 1 4 1.1................................................ 5 1. A............................................... 6 1.3 B............................................... 7 8.1 A...............................................
1. z dr er r sinθ dϕ eϕ r dθ eθ dr θ dr dθ r x 0 ϕ r sinθ dϕ r sinθ dϕ y dr dr er r dθ eθ r sinθ dϕ eϕ 2. (r, θ, φ) 2 dr 1 h r dr 1 e r h θ dθ 1 e θ h
IB IIA 1 1 r, θ, φ 1 (r, θ, φ)., r, θ, φ 0 r
授業研究第1日目
1 1 1 0. (sextant) ( ) 2 1. IB I AB I AI E H H E B GHE CIHE ( ) 2 2 I H A (0 ) ( ) 3 2 2 θ = α + γ β + γ = θ + α β + γ = ( α + γ ) + α β = 2 α + γ γ C H CIG ( ) 4 2. John Hadley 1731 5 ( (octant)) Captain
NL10
Information September, 2006 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10 September, 2006 3 2006 4 Japanese Association for Molecular Target Therapy of Cancer News Letter
指数関数的進化企業に及ぼす弱い連携の影響 日産自動車, 富士フイルム, 川崎重工業のイノベーションの源泉 1 115 12 13 14 15 16 2 21 22 23 24 25 3 31 32 321 322 323 332 4 41 42 43 5-17 - 18 1 115 4 5 9 1 5 5 2 152045 2 3 12015 22015 1000111000 100111200 112
研修コーナー
l l l l l l l Department of Obstetrics and Gynecology, Fukui Medical University, Fukui l l l l l l µ l β β l α l µ µ l l l l Department of Obstetrics and Gynecology, Gifu University School of Medicine,
日本医科大学医学会雑誌第8巻第1号
Xenopus laevis in situ μ μ Xenopus laevis Xenopus laevis Xenopus laevis UGT1A1 UGT1A1 IL28B KRAS UGT1A1 UGT1A128 UGT UGT1A1 UGT1A128 UGT1A1 286 UGT1A1 UGT1A1 28 6 UGT UGT UGT1A128 UGT IL28B UGT1A1
#A A A F, F d F P + F P = d P F, F y P F F x A.1 ( α, 0), (α, 0) α > 0) (x, y) (x + α) 2 + y 2, (x α) 2 + y 2 d (x + α)2 + y 2 + (x α) 2 + y 2 =
#A A A. F, F d F P + F P = d P F, F P F F A. α, 0, α, 0 α > 0, + α +, α + d + α + + α + = d d F, F 0 < α < d + α + = d α + + α + = d d α + + α + d α + = d 4 4d α + = d 4 8d + 6 http://mth.cs.kitmi-it.c.jp/
CVMに基づくNi-Al合金の
CV N-A (-' by T.Koyama ennard-jones fcc α, β, γ, δ β α γ δ = or α, β. γ, δ α β γ ( αβγ w = = k k k ( αβγ w = ( αβγ ( αβγ w = w = ( αβγ w = ( αβγ w = ( αβγ w = ( αβγ w = ( αβγ w = ( βγδ w = = k k k ( αγδ
9 5 ( α+ ) = (α + ) α (log ) = α d = α C d = log + C C 5. () d = 4 d = C = C = 3 + C 3 () d = d = C = C = 3 + C 3 =
5 5. 5.. A II f() f() F () f() F () = f() C (F () + C) = F () = f() F () + C f() F () G() f() G () = F () 39 G() = F () + C C f() F () f() F () + C C f() f() d f() f() C f() f() F () = f() f() f() d =
2 2 1?? 2 1 1, 2 1, 2 1, 2, 3,... 1, 2 1, 3? , 2 2, 3? k, l m, n k, l m, n kn > ml...? 2 m, n n m
2009 IA I 22, 23, 24, 25, 26, 27 4 21 1 1 2 1! 4, 5 1? 50 1 2 1 1 2 1 4 2 2 2 1?? 2 1 1, 2 1, 2 1, 2, 3,... 1, 2 1, 3? 2 1 3 1 2 1 1, 2 2, 3? 2 1 3 2 3 2 k, l m, n k, l m, n kn > ml...? 2 m, n n m 3 2
/ 3 1 / 3 / 3 1 /
8-18-29 3 291415 297 1-11-4 3/31/ 3/31/ 29 8 22 29 1 17 24 8-1 29 [1] PCB [2] HCB [3] [4] [5] DDT [6-1] p,p'-ddt [6-2] p,p'-dde pg/l ( ) nd 2,4 (46/47) 2.9 18 (47/47) 84 12 pg/g-dry ( ) nd 61, (61/62)
1 3 1.1.......................... 3 1............................... 3 1.3....................... 5 1.4.......................... 6 1.5........................ 7 8.1......................... 8..............................
日本分子第5巻2号_15特別講演・シンポジウム.indd
25 JSMI Report JSMI Report 26 41 JSMI Report JSMI Report 42 JSMI Report 54 55 JSMI Report JSMI Report 56 57 JSMI Report JSMI Report 58 59 JSMI Report JSMI Report 60 61 JSMI Report β JSMI Report 62 63 JSMI
1. 1 A : l l : (1) l m (m 3) (2) m (3) n (n 3) (4) A α, β γ α β + γ = 2 m l lm n nα nα = lm. α = lm n. m lm 2β 2β = lm β = lm 2. γ l 2. 3
1. 1 A : l l : (1) l m (m 3) (2) m (3) n (n 3) (4) A 2 1 2 1 2 3 α, β γ α β + γ = 2 m l lm n nα nα = lm. α = lm n. m lm 2β 2β = lm β = lm 2. γ l 2. 3 4 P, Q R n = {(x 1, x 2,, x n ) ; x 1, x 2,, x n R}
ID POS F
01D8101011L 2005 3 ID POS 2 2 1 F 1... 1 2 ID POS... 2 3... 4 3.1...4 3.2...4 3.3...5 3.4 F...5 3.5...6 3.6 2...6 4... 8 4.1...8 4.2...8 4.3...8 4.4...9 4.5...10 5... 12 5.1...12 5.2...13 5.3...15 5.4...17
漸化式のすべてのパターンを解説しましたー高校数学の達人・河見賢司のサイト
https://www.hmg-gen.com/tuusin.html https://www.hmg-gen.com/tuusin1.html 1 2 OK 3 4 {a n } (1) a 1 = 1, a n+1 a n = 2 (2) a 1 = 3, a n+1 a n = 2n a n a n+1 a n = ( ) a n+1 a n = ( ) a n+1 a n {a n } 1,
「スウェーデン企業におけるワーク・ライフ・バランス調査 」報告書
1 2004 12 2005 4 5 100 25 3 1 76 2 Demoskop 2 2004 11 24 30 7 2 10 1 2005 1 31 2 4 5 2 3-1-1 3-1-1 Micromediabanken 2005 1 507 1000 55.0 2 77 50 50 /CEO 36.3 37.4 18.1 3-2-1 43.0 34.4 / 17.6 3-2-2 78 79.4
NL11
information September, 2007 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11 September, 2007 3 2007 4 Japanese Association for Molecular Target Therapy of Cancer News Letter
untitled
( ) δ x V A A V V + x x δ A + x x δ x A V Q AV A+ δx V + δx V A A V AV + A δx+ V δx+ δx V A A δx+ V δx V A A + V ( ) ( AV ) AV Constant Q 1 Text 7.1 ( ) P1 7 7.P8 5 D v g z x + x 1 v ( v+ x ) g + x z z
09 II 09/12/ (3D ) f(, y) = 2 + y 2 3D- 1 f(0, 0) = 2 f(1, 0) = 3 f(0, 1) = 4 f(1, 1) = 5 f( 1, 2) = 6 f(0, 1) = z y (3D ) f(, y) = 2 + y
09 II 09/12/21 1 1 7 1.1 I 2D II 3D f() = 3 6 2 + 9 2 f(, y) = 2 2 + 2y + y 2 6 4y f(1) = 1 3 6 1 2 9 1 2 = 2 y = f() f(3, 2) = 2 3 2 + 2 3 2 + 2 2 6 3 4 2 = 8 z = f(, y) y 2 1 z 8 3 2 y 1 ( y ) 1 (0,
免疫Ⅱ
100 100 100 1990 127 DNA DNA DNA DNA hybridization DNA RNA DNA DNA 128 12 µδγαε 129 300 1,200 500 50012 4 24,000 1,20024,000 2.910 7 10 8 rejection major histocompatibility complex MHC MHC MHC 130 MHC
数学概論I
{a n } M >0 s.t. a n 5 M for n =1, 2,... lim n a n = α ε =1 N s.t. a n α < 1 for n > N. n > N a n 5 a n α + α < 1+ α. M := max{ a 1,..., a N, 1+ α } a n 5 M ( n) 1 α α 1+ α t a 1 a N+1 a N+2 a 2 1 a n
r 1 m A r/m i) t ii) m i) t B(t; m) ( B(t; m) = A 1 + r ) mt m ii) B(t; m) ( B(t; m) = A 1 + r ) mt m { ( = A 1 + r ) m } rt r m n = m r m n B
1 1.1 1 r 1 m A r/m i) t ii) m i) t Bt; m) Bt; m) = A 1 + r ) mt m ii) Bt; m) Bt; m) = A 1 + r ) mt m { = A 1 + r ) m } rt r m n = m r m n Bt; m) Aert e lim 1 + 1 n 1.1) n!1 n) e a 1, a 2, a 3,... {a n
2 ID POS 1... 1 2... 2 2.1 ID POS... 2 2.2... 3 3... 5 3.1... 5 3.2... 6 3.2.1... 6 3.2.2... 7 3.3... 7 3.3.1... 7 3.3.2... 8 3.3.3... 8 3.4... 9 4... 11 4.1... 11 4.2... 15 4.3... 27 5... 35... 36...
さくらの個別指導 ( さくら教育研究所 ) 1 φ = φ 1 : φ [ ] a [ ] 1 a : b a b b(a + b) b a 2 a 2 = b(a + b). b 2 ( a b ) 2 = a b a/b X 2 X 1 = 0 a/b > 0 2 a
![さくらの個別指導 ( さくら教育研究所 ) 1 φ = φ 1 : φ [ ] a [ ] 1 a : b a b b(a + b) b a 2 a 2 = b(a + b). b 2 ( a b ) 2 = a b a/b X 2 X 1 = 0 a/b > 0 2 a](/thumbs/97/131721994.jpg "さくらの個別指導 ( さくら教育研究所 ) 1 φ = φ 1 : φ [ ] a [ ] 1 a : b a b b(a + b) b a 2 a 2 = b(a + b). b 2 ( a b ) 2 = a b a/b X 2 X 1 = 0 a/b > 0 2 a")
φ + 5 2 φ : φ [ ] a [ ] a : b a b b(a + b) b a 2 a 2 b(a + b). b 2 ( a b ) 2 a b + a/b X 2 X 0 a/b > 0 2 a b + 5 2 φ φ : 2 5 5 [ ] [ ] x x x : x : x x : x x : x x 2 x 2 x 0 x ± 5 2 x x φ : φ 2 : φ ( )
.\ /......
教育 研究 社会貢献活動報告 香 川 医 科 大 学 平成１ ３年度 香川医科大学自己点検評価委員会 γ α β β β α β β γ γ α β αβ µ Anopheles Bolbosoma Leishmania Pneumocystis carinii P. carinii Bolbosoma Leishmania Anopheles Plasmodium
春期講座 ~ 極限 1 1, 1 2, 1 3, 1 4,, 1 n, n n {a n } n a n α {a n } α {a n } α lim n an = α n a n α α {a n } {a n } {a n } 1. a n = 2 n {a n } 2, 4, 8, 16,
春期講座 ~ 極限 1 1, 1 2, 1 3, 1 4,, 1 n, n n {a n } n a n α {a n } α {a n } α lim an = α n a n α α {a n } {a n } {a n } 1. a n = 2 n {a n } 2, 4, 8, 16, 32, n a n {a n } {a n } 2. a n = 10n + 1 {a n } lim an
BD = a, EA = b, BH = a, BF = b 3 EF B, EOA, BOD EF B EOA BF : AO = BE : AE, b : = BE : b, AF = BF = b BE = bb. () EF = b AF = b b. (2) EF B BOD EF : B
2000 8 3.4 p q θ = 80 B E a H F b θ/2 O θ/2 D A B E BD = a, EA = b, BH = a, BF = b 3 EF B, EOA, BOD EF B EOA BF : AO = BE : AE, b : = BE : b, AF = BF = b BE = bb. () EF = b AF = b b. (2) EF B BOD EF :
コロナ社 Q&A Question and Answer Q&A
Q&A Question and Answer Q&A ii Q&A 1999 Q&A Q&A Q&A 8 Q&A 2007 2 1. 1.1... 1 1.1.1... 1 1.1.2... 6 1.2... 7 1.2.1... 7 1.2.2... 11 1.3... 18 1.3.1... 18 1.3.2... 20... 25 2. 2.1... 26 2.2... 33... 38 3.
kogi dvi
10 4 23 ( ) email: tanikawa.ky@nao.ac.jp I. ( ) II. : III. ( ) 1 I. : ( ) :, : :, :? : = : =, ( ). 2 1.... ( ).. (,,,, ),,, ( ) ( ). ( )... ( ).?. 3 1: ( T)... 19 F.R. Stephenson 1990 ΔT 4 II. : (i) (ii))
Chapter9 9 LDPC sum-product LDPC 9.1 ( ) 9.2 c 1, c 2, {0, 1, } SUM, PROD : {0, 1, } {0, 1, } SUM(c 1, c 2,, c n ) := { c1 + + c n (c n0 (1 n
9 LDPC sum-product 9.1 9.2 LDPC 9.1 ( ) 9.2 c 1, c 2, {0, 1, } SUM, PROD : {0, 1, } {0, 1, } SUM(c 1, c 2,, c n ) := { c1 + + c n (c n0 (1 n 0 n)) ( ) 0 (N(0 c) > N(1 c)) PROD(c 1, c 2,, c n ) := 1 (N(0
住宅ローンのリスク管理
NSSOL & CPC 2008 (p.23) Credit Pricing Corp. @ Now Printing PD i 1 i 2 t = 1 α t Now Printing T i i i 1 1 2 2 n n T exp( βx ) βx = β x + β x + Lβ x x i DTI x i Now Printing Now Printing Now Printing
,398 4% 017,
6 3 JEL Classification: D4; K39; L86,,., JSPS 34304, 47301.. 1 01301 79 1 7,398 4% 017,390 01 013 1 1 01 011 514 8 1 Novos and Waldman (1984) Johnson (1985) Chen and Png (003) Arai (011) 3 1 4 3 4 5 0
ALM
ALM 4 60025480 1 1.1 1.1.1 1.1.2 1.2 ALM 2. 2.11 2.1.1 2.1.2 2.2 2.3 3. 3.1 3.1.1 3.1.2 3.1.3 3.1.4 3.2 3.2.1 3.2.2 4. 4.1 4.1.1 4.1.2 4.1.3 4.2 4.2.1 4.2.2 4.2.3 5. 5.1 5.1.1 5.1.2 5.2 2 6. 6.1 6.2 6.1.1